AxoGen Inc. (NASDAQ: AXGN) Attends 31st Annual ROTH Conference
AxoGen (NASDAQ: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The company is helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. AxoGen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. AxoGen also offers AcroVal Neurosensory & Motor Testing System and AxoTouch Two-Point Discriminator, evaluation and…







